“hepatitis”的搜索结果，显示 211-220 项，共有 11990 项

1. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial compares the effect of high dose chemotherapy and the patients' own (autologous) stem cells to observation only in patients with ...

2. 血液科- 临床试验- 妙佑医疗国际

   The objectives of this study are to analyze impact of radiation on fertility, to correlate the clinical outcome of fertility after chemotherapy and or ...

3. 血液科- 临床试验- 妙佑医疗国际

   Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these patients ...

4. 血液科- 临床试验- 妙佑医疗国际

   This phase III trial compares the effect of high dose chemotherapy and the patients' own (autologous) stem cells to observation only in patients with ...

5. 外科 - 医生 - 妙佑医疗国际

   ... hepatitis, Polycystic liver disease, Polycystic kidney disease, End-stage renal disease, Budd-Chiari syndrome, Metabolic liver disease. 显示更多擅长领域 针对 ...

6. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to develop and maintain a registry of clinical data and biological specimens from patients with immune system related blood ...

7. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

8. 血液科- 临床试验- 妙佑医疗国际

   DALY II USA is a phase II, multi-center, single arm study to evaluate the efficacy, safety, and pharmacokinetics of zamtocabtagene autoleucel ...

9. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

10. 血液科- 临床试验- 妙佑医疗国际

    Rochester, Minn., Scottsdale/Phoenix, Ariz. This phase I/II trial studies the side effects and best dose of romidepsin and lenalidomide when combined with ...